Phase I / II clinical trial of the OP-01 for acute lymphoblastic leukemia and lymphoblastic lymphoma (Erwinia L- asparaginase)

Trial Profile

Phase I / II clinical trial of the OP-01 for acute lymphoblastic leukemia and lymphoblastic lymphoma (Erwinia L- asparaginase)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Crisantaspase (Primary) ; Pirarubicin; Prednisolone; Vincristine
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 01 Sep 2017 Results published in the Pediatric Blood and Cancer
    • 11 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top